aphria news
Aphria is aware of short-seller report
2018-12-03 15:05 ET - News Release
An anonymous director reports
APHRIA STATEMENT REGARDING SHORT-SELLER REPORT
Aphria Inc. is aware of a short-seller report released earlier today which Aphria believes is a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders.
Investors should exercise caution in relying on the misrepresentations and distortions contained in the report and recognize that, by its own admission, Hindenburg Research "stands to realize significant gains in the event that the price of any stock covered herein declines." The report also states that, "Hindenburg Research makes no representation, express or implied, as to the accuracy, timeliness or completeness of [the information in report]."
The report makes reference to the company's LatAm acquisition, which closed on Sept. 27, 2018. In connection with this transaction, the board of directors of Aphria confirmed that it received financial advice and a fairness opinion from a reputable firm that the consideration to be offered by Aphria in respect of the transaction was fair, from a financial point of view, to Aphria and its shareholders.
Shareholders should refer to the company's disclosure documents filed with Canadian and U.S. securities regulatory authorities, which are available on-line under the company's SEDAR profile, the company's EDGAR profile or on the company's website.
About Aphria Inc.
Aphria is a leading global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ont., the greenhouse capital of Canada, Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible.
We seek Safe Harbor.